Mitsubishi UFJ Morgan Stanley Securities’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-60
| Closed | -$43K | – | 157 |
|
2022
Q4 | $43K | Sell |
60
-60
| -50% | -$43K | 0.38% | 34 |
|
2022
Q3 | $83K | Hold |
120
| – | – | 1.12% | 15 |
|
2022
Q2 | $71K | Hold |
120
| – | – | 0.1% | 18 |
|
2022
Q1 | $84K | Sell |
120
-120
| -50% | -$84K | 0.07% | 13 |
|
2021
Q4 | $152K | Buy |
240
+10
| +4% | +$6.33K | 0.07% | 44 |
|
2021
Q3 | $139K | Buy |
230
+80
| +53% | +$48.3K | 0.13% | 20 |
|
2021
Q2 | $84K | Buy |
+150
| New | +$84K | 0.62% | 29 |
|
2014
Q4 | $41K | Hold |
100
| – | – | 0.08% | 60 |
|
2014
Q3 | $36K | Hold |
100
| – | – | 0.1% | 82 |
|
2014
Q2 | $28K | Hold |
100
| – | – | 0.08% | 96 |
|
2014
Q1 | $30K | Sell |
100
-110
| -52% | -$33K | 0.08% | 99 |
|
2013
Q4 | $58K | Sell |
210
-30
| -13% | -$8.29K | 0.1% | 47 |
|
2013
Q3 | $75K | Buy |
240
+90
| +60% | +$28.1K | 0.12% | 33 |
|
2013
Q2 | $34K | Buy |
+150
| New | +$34K | 0.11% | 110 |
|